Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06348212
Other study ID # 2022-11-008C
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2024
Est. completion date December 2025

Study information

Verified date April 2024
Source Taipei Veterans General Hospital, Taiwan
Contact Chieh Lee, Medical student
Phone +886-0971839369
Email jason.jay.lee@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to test whether the intervention of probiotics supplement can improve symptoms of long covid syndrome. Participants will be given probiotics or placebo capsules for two month. Symptom questionnaires, cognitive function, eeg and fecal sample are recorded/collected before and after the supplement. Researchers will compare the probiotic group and the placebo to see if probiotic supplement really make differences.


Description:

After the pandemic of covid-19, people found out that not only does it cause acute respiratory system symptoms, but it also affect many other systems even long after the acute symptoms have resolved, which is named the Long Covid Syndrome. Studies have shown that the gut microbiota of those suffering from long covid syndrome differ from that of healthy people and those who recovered from covid without getting long covid syndrome, which implied the possibility of probiotic supplement being an effective treatment to long covid. This double-blind parallel randomized control trail plans to supply participants with probiotics or placebo fortwo months. Symptom questionnaires, cognitive function, eeg and fecal sample will be recorded/collected before and after the supplement. Researchers will compare the two groups to see if they differ in the above measure and to see if the differences in symptoms and cognitive functions change correlate with gut microbiota change and fecal metabolite change.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 2025
Est. primary completion date August 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - 20 to 80 year old - had been infected by SARS-CoV-2 - Stable vital signs - Have brain fog conplaint - MoCA<30 at baseline Exclusion Criteria: - refuse to join the study or refuse to sign the Informed Consent Form - have other neurological disease that may affect cognitive function, such as Parkinson disease, Seizure, etc. - have other gastrointestinal disease that may affect cognitive function, including tumors. - severe hearing loss or visual loss that may hinder cognitive function tests - Taken anti-seizure drug in 7 days. - Already taking probiotics supplement regularly - Taken antibiotics in two weeks - taking stool softener or laxative regularly - have valvular heart disease - have congenital or acquired immunodeficiency or is under iimmunosuppressant therapy - Pregnant or plans to be pregnant - BMI>30 - Have been performed severe gastrointestinal surgery(s) - Severe liver, kidney, cardiovascular, hematologic or metabolic disorder - In critical condition

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Lactobacillus paracasei PS23
2 caps daily use
microcrystalline cellulose
2 caps daily use

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Taipei Veterans General Hospital, Taiwan

Outcome

Type Measure Description Time frame Safety issue
Primary Long covid related symptoms A list of symptoms related to long covid including cough, fatigue. brain fog etc. baseline and two months after probiotic/placebo supplement
Primary Hospital Anxiety and Depression Scale A measurement of the degree of depression and anxiety, with 7 questions each and 0-3 points for each question. Two scores ranging from 0-21 will be calculated, with higher points meaning more severe depression or anxiety. baseline and two months after probiotic/placebo supplement
Primary The Pittsburgh sleep quality index A measurement of the degree of sleep disturbance/disorder. The score ranges from 0-21, with higher points meaning more severe sleep problem. baseline and two months after probiotic/placebo supplement
Primary Fatigue Severity Scale A measurement of the degree of fatigue, with score ranging from 7-49 and higher points meaning more severe fatigue. baseline and two months after probiotic/placebo supplement
Primary GI symptoms Rome Criteria Questionnaire in functional UGI disease and Rome Criteria Questionnaire in IBS are included in the questionnaire are measured to see if probiotic/placebo supplement results in adverse gi events or a change of bowel habits. baseline and two months after probiotic/placebo supplement
Primary Cognitive function-Digit symbol substitution test a list of paired numbers and symbols are given to participants, and they are ask to match symbols to numbers accordingly. The number of question they answer within 90 second will be recorded. baseline and two months after probiotic/placebo supplement
Primary Cognitive function-The Montreal Cognitive Assessment(MoCA) Score ranging from 0-30, with higher meaning better cognitive function baseline and two months after probiotic/placebo supplement
Primary Cognitive function-Color Trails making Test The test is composed of two parts, easy and hard. The time taken to finish the two parts are recorded baseline and two months after probiotic/placebo supplement
Primary Cognitive function-Cogstate Brief Battery (CBB) A cognitive test on ipad. baseline and two months after probiotic/placebo supplement
Primary EEG 2 minutes of resting-state eye-open eeg were recored. After a brief rest, a working memory task will be repeated for 12 times.
In the task, subjects will be shown balls in a 5*5 chart, the location of which They are asked to remember. 6 second later, they are shown another ball, and they will be asked if the location of the newly shown ball are identical with any of the originally shown balls.
baseline and two months after probiotic/placebo supplement
Primary Gut microbiota Subjects will be asked to collect their fecal sample and the bacterial DNA/RNA will be extracted and analyzed. baseline and two months after probiotic/placebo supplement
Primary Fecal metabolite Subjects will be asked to collect their fecal sample and the SCFAs in the sample will be measured. baseline and two months after probiotic/placebo supplement
See also
  Status Clinical Trial Phase
Completed NCT05712005 - Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Completed NCT05343208 - Effectiveness of Online Therapy to Prevent Burnout N/A
Active, not recruiting NCT05143294 - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT05267730 - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions N/A
Completed NCT03987477 - Online Intervention to Modify Interpretation Biases in Depression N/A
Completed NCT03695003 - Cognitive Effects of Sage in Healthy Humans N/A
Completed NCT05075850 - Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Completed NCT03674281 - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System N/A
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Active, not recruiting NCT05229705 - Exercise in Older Adults at Risk for Type 2 Diabetes N/A
Suspended NCT05001789 - Cognitive Functioning in Opioid Use Disorder N/A
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT03657537 - Effects of Ketone Bodies on Cognition in Type 2 Diabetes Phase 1
Completed NCT05543811 - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology N/A
Recruiting NCT05699226 - Amplitude Titration to Improve ECT Clinical Outcomes N/A
Recruiting NCT05026541 - Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators N/A
Active, not recruiting NCT03255499 - Efficacy of the MovinCog Intervention in Children N/A
Not yet recruiting NCT06252376 - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD N/A